Featured in this VAM daily edition:
- F/BEVAR has high technical success and low mortality in chronic post-dissection TAAA (p. 1 and 3)
- Systemic heparin during TEVAR deemed safe for selected traumatic brain injury patients (p. 6)
- Female sex ‘should be considered an independent risk factor’ for new stroke occurrence after carotid revascularization in symptomatic patients (p. 12)
- Talking about women surgeons’ lives and career (p. 15)
